<DOC>
	<DOC>NCT01148368</DOC>
	<brief_summary>The purpose of this study is to compare and evaluate the pharmacokinetic characteristics and the safety of fimasartan in renal impairment patients and healthy volunteers.</brief_summary>
	<brief_title>A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>&lt;Renal impairment patient&gt; age: 2065 years eGFR: &lt; 30ml/min/1.73m^2 not on dialysis body weight: greater than 55kg written informed consent &lt;Healthy volunteer&gt; age: 2065 years body weight: greater than 55kg written informed consent AST, ALT &gt; 1.5 times of upper normal range positive drug or alcohol screening</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>fimasartan</keyword>
	<keyword>renal impairment</keyword>
	<keyword>hypertension</keyword>
</DOC>